Preparation and characterization of quercetin-loaded solid lipid microparticles for pulmonary delivery

Powder Technology

Volumn 239, Issue , 2013, Pages 183-192

  Silva, Luis Felipe Costa ^a   Kasten, Georgia ^a   de Campos, Carlos Eduardo Maduro ^a   Chinelatto, Adilson Luiz ^b   Lemos Senna, Elenara ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

Author keywords

Pulmonary delivery; Quercetin; Solid lipid microparticles

Indexed keywords

AERODYNAMIC DIAMETERS; FLOWABILITY; IN-VITRO; INHALED PARTICLES; LIPID MICROPARTICLES; LUNG REGIONS; MICRO-PARTICLES; MULTIPATH MODELS; PARTICLE DEPOSITIONS; POLYMORPHIC TRANSITIONS; POWDER FRACTIONS; PREPARATION TECHNIQUE; PULMONARY ADMINISTRATIONS; PULMONARY DELIVERY; QUERCETIN; RELEASE RATE; ROUGH SURFACES; SOLVENT DIFFUSION METHODS; SOY LECITHIN; SPHERICAL SHAPE; TAPPED DENSITY; TOTAL LIPIDS;

FLAVONOIDS; HOMOGENIZATION METHOD; LECITHIN; PHENOLS; SCANNING ELECTRON MICROSCOPY;

FATTY ACIDS;

GLYCEROL BEHENATE; MYRISTIC ACID DERIVATIVE; PHOSPHATIDYLCHOLINE; QUERCETIN; SOLID LIPID NANOPARTICLE; TRIMYRISTIN; UNCLASSIFIED DRUG;

ARTICLE; BULK DENSITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; NANOANALYSIS; NANOFABRICATION; NANOPHARMACEUTICS; PARTICLE SIZE; PHYSICAL CHEMISTRY; POROSITY; POWDER; PROCESS DEVELOPMENT; SCANNING ELECTRON MICROSCOPY; STRUCTURE ANALYSIS; SURFACE PROPERTY; TEMPERATURE SENSITIVITY; X RAY POWDER DIFFRACTION;

EID: 84874408239     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2013.01.037     Document Type: Article

References (36)

1. Wark P.A.B., Gibson P.G. Asthma exacerbations - 3: pathogenesis. Thorax 2006, 61:909-915.
2. Singh A.M., Busse W.W. Asthma exacerbation - 2: aetiology. Thorax 2006, 61:809-816.
3. Bischoff S. Quercetin: potentials in the prevention and therapy of disease. Current Opinion in Clinical Nutrition and Metabolic Care 2008, 11:733-740.
4. Rogério A.P., Dora C.L., Andrade E.L., Chaves J.S., Silva L.F.C., Lemos-Senna E., Calixto J.B. Anti-inflammatory effect of quercetin-loaded microemulsion in the airway allergic inflammatory model in mice. Pharmaceutical Research 2010, 61:288-297.
5. Taylor G., Kellaway I. Pulmonary drug delivery. Drug Delivery and Targeting for Pharmacists and Pharmaceuticals Scientists 2001, 269-291. Taylor & Francis, London. A.M. Hilley, A.W. Lloyd, J. Swarbuck (Eds.).
6. Yang Y., Bajaj N., Xu P., Ohn K., Tsifansku M.D., Yeo Y. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 2009, 30:1947-1953.
7. Patton J.S., Byron P.R. Inhaling medicines: delivering drugs to the body through the lungs. Nature Reviews. Drug Discovery 2007, 6:67-74.
8. Geiser M. Update on macrophage clearance of inhaled micro and nanoparticles. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2010, 23:210-217.
9. Edwards D.A., Hanes J., Caponetti G., Hrkach J., Benjebria A., Eskew L.M., Mintzes J., Deaver D., Lotan N., Langer R. Large pourous particles for pulmonary drug delivery. Science 1997, 276:1868-1971.
10. Edwards D.A., Ben-Jebria A., Langer R. Recent advances in pulmonary drug delivery using large, porous inhaled particles. Journal of Applied Physiology 1998, 85:379-385.
11. Sanna V., Kirschvink N., Gustin P., Gavini E., Reland I., Delattre L., Evrard B. Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech 2004, 5:1-7.
12. Jaspart S., Bertholet P., Piel G., Dogné J.-M., Delattre L., Evrard B. Solid lipid microparticles as a sustained release system for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 2007, 65:47-56.
13. Mezzena M., Scalia S., Young P.M., Traini D. Solid lipid budesonide microparticles for controlled release inhalation therapy. The AAPS Journal 2009, 11:771-778.
14. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 2000, 50:161-177.
15. Mehnert W., Mader K. Solid lipid nanoparticles: production, characterization and Applications. Advanced Drug Delivery Reviews 2001, 47:165-196.
16. Dora C.L., Silva L.F.C., Tagliari M.P., Silva M.A.S., Lemos-Senna E. Formulation study of quercetin-loaded lipid based nanocarriers obtained by hot solvent diffusion method. Latin American Journal of Pharmacy 2011, 30:289-296.
17. Healy A.M., McDonald B.F., Tajber L., Corrigan O.I. Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide. European Journal of Pharmaceutics and Biopharmaceutics 2008, 69:1182-1186.
18. Ungaro F., Bianca R., Giovino C., Miro A., Sorrentino R., Quaglia F., La Rotonda M.I. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycemic activity after delivery to rats lungs. Journal of Controlled Release 2009, 135:25-34.
19. Banakar U.V. Pharmaceutical Dissolution Testing 1992, 55-100. Marcel Dekker, New York. M. Dekker (Ed.).
20. Kim Y.H., Shing K.S. Supercritical fluid-micronized ipratropium bromide for pulmonary drug delivery. Powder Technology 2008, 182:25-32.
21. Hou D.Z., Xue C.S., Huang K.J., Zhu C.H. The production and characterization of solid lipid nanoparticles. Biomaterials 2003, 24:1781-1785.
22. Das S., Ng W.N., Tan R.B.H. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?. European Journal of Pharmaceutical Sciences 2012, 47:139-151.
23. Jaspart S., Piel G., Delatre L., Evrard B. Solid lipid microparticles: formulation, preparation, characterization, drug release and applications. Expert Opinion 2005, 2:75-87.
24. Bosquillon C., Lombry C., Préat V., Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. Journal of Controlled Release 2007, 70:329-339.
25. Vanbever R., Mintzes J.D., Wang J., Nice J., Chen D., Batycky R., Langer R., Edwards D. Formulation and physical characterization of large porous particles for inhalation. Pharmaceutical Research 1999, 16:1735-1741.
26. Vay K., Scheler S., Frieß W. New insight into the pore structure of poly(d, l-lactide-co-glycolide) microspheres. International Journal of Pharmaceutics 2010, 402:20-26.
27. Brubach J.B., Janin V., Mahler B., Bourgaux C., Lessieur P., Roy P., Ollivon M. Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy. International Journal of Pharmaceutics 2007, 336:248-256.
28. Bresson S., El Marssi M., Khelifa B. Raman spectroscopy investigation of various saturated monoacid triglycerides. Chemistry and Physics of Lipids 2005, 134:119-129.
29. ™) and crystallinity of the lipid phase. European Journal of Pharmaceutics and Biopharmaceutics 1999, 47:125-132.
30. Ali H., El-Sayed K., Sylvester P.W., Nazzal S. Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: evidence studies by Differential Scanning Calorimetry (DSC) and Proton Nuclear Magnetic Resonance spectroscopy (1H NMR). Colloids and Surfaces. B, Biointerfaces 2010, 77:286-297.
31. Pawar A.A., Chen D.-R., Venkataraman C. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticles aerosol lipid matrices. International Journal of Pharmaceutics 2012, 430:228-237.
32. Jenning V., Gohla S. Comparison of wax and glyceride solid lipid nanoparticles (SLN). International Journal of Pharmaceutics 2000, 196:219-222.
33. Siepmann J., Siepmann F. Mathematical modeling of drug delivery. International Journal of Pharmaceutics 2008, 364:328-343.
34. D'Souza S.S., DeLuca P.P. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharmaceutical Research 2006, 23:460-474.
35. Abdel-Mottaled M.M.A., Lamprech A. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I. Drug Development and Industrial Pharmacy 2011, 37:178-184.
36. Taylor G., Kellaway I. Pulmonary Drug Delivery 2001, 269-272. Taylor & Francis, London. A. Hillery, A.W. Lloyd, J. Swarbrick (Eds.).